Peroxisomal very long chain fatty acid β-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression

Research output: Contribution to journalArticle

Abstract

Impaired peroxisomal β-oxidation of saturated very long chain fatty acids (VLCFA, ≥C22:0) results in increased VLCFA levels in the tissues and body fluids of patients with disorders of peroxisomal biogenesis (i.e., Zellweger syndrome and neonatal adrenoleukodystrophy) and single peroxisomal protein defects (i.e., X-linked adrenoleukodystrophy (X-ALD) and acyl-CoA oxidase deficiency). We show that SV40T transformation also results in impaired peroxisomal β-oxidation and VLCFA accumulation despite the presence of abundant peroxisomes. To explore the mechanism responsible for this observation, we have examined expression of key components of peroxisomal VLCFA β-oxidation. We found that expression of both acyl-CoA oxidase, the rate limiting enzyme of peroxisomal VLCFA β-oxidation and the adrenoleukodystrophy protein (ALDP), the defective gene product in X-ALD, are reduced after SV40T transformation. Surprisingly, ALDP overexpression by itself restores peroxisomal VLCFA β-oxidation in SV40T-transformed control and X-ALD cells. These results demonstrate that ALDP is a fundamental component in VLCFA peroxisomal β-oxidation and may serve as a 'gatekeeper' for VLCFA homeostasis.

Original languageEnglish (US)
Pages (from-to)91-99
Number of pages9
JournalMolecular Genetics and Metabolism
Volume66
Issue number2
DOIs
StatePublished - Feb 1999

Fingerprint

Adrenoleukodystrophy
Fatty Acids
Oxidation
Peroxisomal Disorders
Acyl-CoA Oxidase
Proteins
Zellweger Syndrome
Peroxisomes
Body fluids
Body Fluids
Homeostasis
Genes
Tissue
Defects
Enzymes

Keywords

  • β-oxidation
  • ALDP
  • Peroxisome SV40T antigen transformation
  • X-linked adrenoleukodystrophy

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{88b2ec2d157b474cba639f5f2c36689c,
title = "Peroxisomal very long chain fatty acid β-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression",
abstract = "Impaired peroxisomal β-oxidation of saturated very long chain fatty acids (VLCFA, ≥C22:0) results in increased VLCFA levels in the tissues and body fluids of patients with disorders of peroxisomal biogenesis (i.e., Zellweger syndrome and neonatal adrenoleukodystrophy) and single peroxisomal protein defects (i.e., X-linked adrenoleukodystrophy (X-ALD) and acyl-CoA oxidase deficiency). We show that SV40T transformation also results in impaired peroxisomal β-oxidation and VLCFA accumulation despite the presence of abundant peroxisomes. To explore the mechanism responsible for this observation, we have examined expression of key components of peroxisomal VLCFA β-oxidation. We found that expression of both acyl-CoA oxidase, the rate limiting enzyme of peroxisomal VLCFA β-oxidation and the adrenoleukodystrophy protein (ALDP), the defective gene product in X-ALD, are reduced after SV40T transformation. Surprisingly, ALDP overexpression by itself restores peroxisomal VLCFA β-oxidation in SV40T-transformed control and X-ALD cells. These results demonstrate that ALDP is a fundamental component in VLCFA peroxisomal β-oxidation and may serve as a 'gatekeeper' for VLCFA homeostasis.",
keywords = "β-oxidation, ALDP, Peroxisome SV40T antigen transformation, X-linked adrenoleukodystrophy",
author = "Braiterman, {Lelita T.} and Watkins, {Paul A} and Moser, {Ann B.} and Smith, {Kirby D.}",
year = "1999",
month = "2",
doi = "10.1006/mgme.1998.2789",
language = "English (US)",
volume = "66",
pages = "91--99",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Peroxisomal very long chain fatty acid β-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression

AU - Braiterman, Lelita T.

AU - Watkins, Paul A

AU - Moser, Ann B.

AU - Smith, Kirby D.

PY - 1999/2

Y1 - 1999/2

N2 - Impaired peroxisomal β-oxidation of saturated very long chain fatty acids (VLCFA, ≥C22:0) results in increased VLCFA levels in the tissues and body fluids of patients with disorders of peroxisomal biogenesis (i.e., Zellweger syndrome and neonatal adrenoleukodystrophy) and single peroxisomal protein defects (i.e., X-linked adrenoleukodystrophy (X-ALD) and acyl-CoA oxidase deficiency). We show that SV40T transformation also results in impaired peroxisomal β-oxidation and VLCFA accumulation despite the presence of abundant peroxisomes. To explore the mechanism responsible for this observation, we have examined expression of key components of peroxisomal VLCFA β-oxidation. We found that expression of both acyl-CoA oxidase, the rate limiting enzyme of peroxisomal VLCFA β-oxidation and the adrenoleukodystrophy protein (ALDP), the defective gene product in X-ALD, are reduced after SV40T transformation. Surprisingly, ALDP overexpression by itself restores peroxisomal VLCFA β-oxidation in SV40T-transformed control and X-ALD cells. These results demonstrate that ALDP is a fundamental component in VLCFA peroxisomal β-oxidation and may serve as a 'gatekeeper' for VLCFA homeostasis.

AB - Impaired peroxisomal β-oxidation of saturated very long chain fatty acids (VLCFA, ≥C22:0) results in increased VLCFA levels in the tissues and body fluids of patients with disorders of peroxisomal biogenesis (i.e., Zellweger syndrome and neonatal adrenoleukodystrophy) and single peroxisomal protein defects (i.e., X-linked adrenoleukodystrophy (X-ALD) and acyl-CoA oxidase deficiency). We show that SV40T transformation also results in impaired peroxisomal β-oxidation and VLCFA accumulation despite the presence of abundant peroxisomes. To explore the mechanism responsible for this observation, we have examined expression of key components of peroxisomal VLCFA β-oxidation. We found that expression of both acyl-CoA oxidase, the rate limiting enzyme of peroxisomal VLCFA β-oxidation and the adrenoleukodystrophy protein (ALDP), the defective gene product in X-ALD, are reduced after SV40T transformation. Surprisingly, ALDP overexpression by itself restores peroxisomal VLCFA β-oxidation in SV40T-transformed control and X-ALD cells. These results demonstrate that ALDP is a fundamental component in VLCFA peroxisomal β-oxidation and may serve as a 'gatekeeper' for VLCFA homeostasis.

KW - β-oxidation

KW - ALDP

KW - Peroxisome SV40T antigen transformation

KW - X-linked adrenoleukodystrophy

UR - http://www.scopus.com/inward/record.url?scp=0032776070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032776070&partnerID=8YFLogxK

U2 - 10.1006/mgme.1998.2789

DO - 10.1006/mgme.1998.2789

M3 - Article

C2 - 10068511

AN - SCOPUS:0032776070

VL - 66

SP - 91

EP - 99

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 2

ER -